221 related articles for article (PubMed ID: 27401862)
1. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network.
Thiele S; Mantovani G; Barlier A; Boldrin V; Bordogna P; De Sanctis L; Elli FM; Freson K; Garin I; Grybek V; Hanna P; Izzi B; Hiort O; Lecumberri B; Pereda A; Saraff V; Silve C; Turan S; Usardi A; Werner R; de Nanclares GP; Linglart A
Eur J Endocrinol; 2016 Dec; 175(6):P1-P17. PubMed ID: 27401862
[TBL] [Abstract][Full Text] [Related]
2. Inactivating PTH/PTHrP Signaling Disorders.
Mantovani G; Elli FM
Front Horm Res; 2019; 51():147-159. PubMed ID: 30641531
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone resistance syndromes - Inactivating PTH/PTHrP signaling disorders (iPPSDs).
Elli FM; Pereda A; Linglart A; Perez de Nanclares G; Mantovani G
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):941-954. PubMed ID: 30665554
[TBL] [Abstract][Full Text] [Related]
4. Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients.
Pereda A; Elli FM; Thiele S; de Sanctis L; Rothenbuhler A; Hanna P; Francou B; Ertl DA; Perez de Nanclares G; Linglart A; Mantovani G
Eur J Endocrinol; 2021 Feb; 184(2):311-320. PubMed ID: 33270042
[TBL] [Abstract][Full Text] [Related]
5. Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?
Elli FM; Mantovani G
Endocrine; 2021 Jun; 72(3):611-618. PubMed ID: 33179219
[TBL] [Abstract][Full Text] [Related]
6. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
Turan S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
[TBL] [Abstract][Full Text] [Related]
7. Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.
Mantovani G; Spada A; Elli FM
Nat Rev Endocrinol; 2016 Jun; 12(6):347-56. PubMed ID: 27109785
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders.
Truelove A; Mulay A; Prapa M; Casey RT; Adler AI; Offiah AC; Poole KES; Trotman J; Al Hasso N; Park SM
Am J Med Genet A; 2019 Jul; 179(7):1330-1337. PubMed ID: 31041856
[TBL] [Abstract][Full Text] [Related]
9. Pseudohypoparathyroidism.
Cianferotti L; Brandi ML
Minerva Endocrinol; 2018 Jun; 43(2):156-167. PubMed ID: 29125274
[TBL] [Abstract][Full Text] [Related]
10. PTH resistance.
Mantovani G; Elli FM
Mol Cell Endocrinol; 2021 Jul; 531():111311. PubMed ID: 33989717
[TBL] [Abstract][Full Text] [Related]
11. Mild progressive osseous heteroplasia overlap syndrome with PTH and TSH resistance appearing during adolescence and not early childhood.
Ozaki K; Mituboshi A; Nagai M; Nishiyama A; Nishimura G; Morisada N; Iijima K
Endocrine; 2021 Dec; 74(3):685-689. PubMed ID: 34254228
[TBL] [Abstract][Full Text] [Related]
12. Acrodysostosis: A new form of pseudohypoparathyroidism?
Silve C
Ann Endocrinol (Paris); 2015 May; 76(2):110-2. PubMed ID: 25890446
[No Abstract] [Full Text] [Related]
13. Failure of tooth eruption and brachydactyly in pseudohypoparathyroidism are not related to plasma parathyroid hormone-related protein levels.
Reis MT; Matias DT; Faria ME; Martin RM
Bone; 2016 Apr; 85():138-41. PubMed ID: 26855372
[TBL] [Abstract][Full Text] [Related]
14. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.
Elli FM; Barbieri AM; Bordogna P; Ferrari P; Bufo R; Ferrante E; Giardino E; Beck-Peccoz P; Spada A; Mantovani G
Bone; 2013 Oct; 56(2):276-80. PubMed ID: 23796510
[TBL] [Abstract][Full Text] [Related]
15. Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism.
Del Sindaco G; Berkenou J; Pagnano A; Rothenbuhler A; Arosio M; Mantovani G; Linglart A
J Clin Endocrinol Metab; 2023 Oct; 108(11):2961-2969. PubMed ID: 37098127
[TBL] [Abstract][Full Text] [Related]
16. Pseudohypoparathyroidism type Ib in 2015.
Mantovani G; Elli FM
Ann Endocrinol (Paris); 2015 May; 76(2):101-4. PubMed ID: 25910998
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic considerations in "constitutional bone diseases"].
Gomirato G
Minerva Pediatr; 1991 Apr; 43(4):317-21. PubMed ID: 1870539
[TBL] [Abstract][Full Text] [Related]
18. New insights into thyroid dysfunction in patients with inactivating parathyroid hormone/parathyroid hormone-related protein signalling disorder (the hormonal and ultrasound aspects): One-centre preliminary results.
Januś D; Roztoczyńska D; Janeczko M; Starzyk JB
Front Endocrinol (Lausanne); 2022; 13():1012658. PubMed ID: 36213284
[TBL] [Abstract][Full Text] [Related]
19. Pseudohypoparathyroidism.
Linglart A; Levine MA; Jüppner H
Endocrinol Metab Clin North Am; 2018 Dec; 47(4):865-888. PubMed ID: 30390819
[TBL] [Abstract][Full Text] [Related]
20. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
Stögmann W
Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
